Characteristics | n | % | (95% CI) |
---|---|---|---|
Sex | 337 | 100 | |
Male | 128 | 37.0 | (33.0–41.3) |
Female | 207 | 62.5 | (57.9–66.8) |
Unknown | 2 | 0.5 | (0.1–2.3) |
Mean age, years | 31.0 | (29.6–32.4) | |
ART status | 337 | 100 | |
Naïve | 268 | 79.1 | (69.7–86.2) |
Previous exposure to ART | 69 | 20.9 | (13.8–30.0) |
WHO clinical staginga | 323 | 100 | |
I | 64 | 19.8 | – |
II | 74 | 22.9 | – |
III | 172 | 51.3 | – |
IV | 13 | 4.0 | – |
CD4 cell countsa | 236 | 100 | |
≤ 250 cells/mm3 | 146 | 61.9 | – |
> 250 cells/mm3 | 90 | 38.1 | – |
NNRTI-based first-line ART | 312 | 100 | |
TDF-based | 267 | 84.0 | (63.1–94.2) |
AZT-based | 43 | 15.4 | (5.7–35.4) |
d4T-based | 2 | 0.5 | (0.1–3.5) |